Murtaza A Chishti1, Ajay Meena2, Gaurav Goyal3, Premraj Nagarwal4, Varun Chhabra5, Aashish Jain6, Deepesh Aggarwal7, Ramanand D. Sinha8
The aim of this study was to determine the effectiveness and results of repair of Organic Tricuspid Valve disease. INTRODUCTION: since tricuspid valve disease most often found in association with other valve disease. Isolated tricuspid valve disease is rare. Pattern of involvement of tricuspid valve disease shows functional (75%) and primary (organic) in (25%). Surgical repair of organic tricuspid valve disease often fails because of abnormal valve. This usually leads to limited options. This study examines our experience of tricuspid valve repair with autologous pericardium for organic tricuspid valve disease. MATERIAL AND METHODS: From Jan 2014 to May 2015, 22 patients underwent repairs for organic tricuspid valve disease. The patient aged 15 to 65 years and all were in New York Heart Association (NYHA) class of III or IV. All patients presented with severe tricuspid disease coexisting with other cardiac pathology, usually left-sided heart valve disease. Repair techniques included Commisurotomy, division of secondary chordae, Glutaraldehyde treated autologous pericardial patch augmentation of tricuspid valve leaflets, anterior papillary muscle advancement etc with or without ring/suture annuloplasty. Follow-up duration was 3 to 18 months. RESULTS: No deaths or late reoperations occurred. All patients demonstrated clinical improvements on follow up. Echocardiographic studies before hospital discharge showed less than mild tricuspid regurgitation in all patients except one.
